Hims & Hers Health Inc

HIMS has entered a Lockout Rally marked by long green candles, stacked EMAs, and rising volume driven by forced short covering. Medium-term structure remains bullish after reclaiming key moving averages, and the pattern override permits immediate participation despite short-term extension. Continuation is expected on pullbacks into the EMA cluster.

• ↑Q1 ’25 revenue jumped 111% YoY to $586 M, driven by new products and subscriber growth
• ↑2.6 M subscribers with ~90% retention indicate strong consumer demand and brand loyalty
• ↓Regulatory scrutiny on peptide and GLP-1 treatments may delay key product rollouts